Side-by-side comparison of AI visibility scores, market position, and capabilities
Tesla (TSLA) reported $97.7B revenue in FY2024, up 1% YoY. 1.8M vehicles delivered. Market cap ~$900B. 140,000+ employees. Austin, TX. FSD (Full Self-Driving), Optimus humanoid robot, Dojo AI training supercomputer.
Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as chairman and lead investor in 2004. The company was built on the premise that electric vehicles could be desirable, high-performance automobiles — not compromise products — and that compelling EVs would accelerate the world's transition to sustainable energy. Musk's strategy, articulated in the 2006 "Secret Master Plan," was to start with a premium sports car (Roadster), use the proceeds to build a more affordable sedan (Model S), and ultimately produce a mass-market vehicle (Model 3). Tesla trades on Nasdaq under the ticker TSLA and has since expanded its mission to encompass solar energy, stationary storage, and autonomous driving.\n\nTesla's product portfolio spans the Model 3 (sedan), Model Y (compact SUV — the world's best-selling vehicle in 2023), Model S (premium sedan), Model X (premium SUV), Cybertruck (full-size electric pickup), and the Tesla Semi commercial truck. The company's energy business includes the Powerwall home battery, Megapack utility-scale storage, and Solar Roof installations. Tesla's Full Self-Driving (FSD) software suite provides driver assistance capabilities up to supervised autonomous driving, with a paid subscription and per-vehicle purchase option. Tesla operates a proprietary Supercharger network of 50,000+ charging stations globally, a significant infrastructure moat that has become accessible to competing EV brands through industry NACS adapter adoption.\n\nTesla reported FY2024 revenue of $97.7 billion, up approximately 1% year over year, with 1.8 million vehicles delivered and a market capitalization of approximately $900 billion — making it one of the ten most valuable companies in the world. The company employs 140,000+ people and operates Gigafactories in Austin (Texas), Fremont (California), Shanghai, Berlin, and Nevada. Despite increasing competition from BYD in China and European automakers globally, Tesla's vertical integration, software-defined vehicle architecture, FSD capability, and energy storage business position it as the defining company of the electric transportation and distributed energy era.
World's dominant DNA sequencing platform with ~80% market share; ~$4.34B FY2025 revenue. Powers clinical genomics, oncology diagnostics, and population-scale sequencing.
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applications. The company's sequencing-by-synthesis (SBS) chemistry and NovaSeq, NextSeq, and MiSeq instrument platforms have become the standard infrastructure for genomic research, clinical oncology, reproductive health, and infectious disease diagnostics worldwide.\n\nIllumina's business model combines high-margin consumable sales (flow cells, reagent kits) with instrument placements, creating a razor-and-blades recurring revenue structure. Its clinical sequencing segment showed accelerating growth in 2025, with clinical consumables revenue up 20% year-over-year in Q4. The company is expanding into spatial transcriptomics and multi-omics with new instruments unveiled at AGBT 2025, broadening its addressable market.\n\nIllumina reported $4.34 billion in FY2025 revenue and guides to $4.5–$4.6 billion for FY2026, with non-GAAP operating margins of ~23%. Having divested Grail (its liquid biopsy subsidiary) following regulatory pressure, Illumina is refocused on its core sequencing franchise and positioned to benefit from continued clinical adoption of genomic medicine.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.